go back

Ciltacabtagene Autoleucel (Carvykti) CAR-T Therapy

Louisiana rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $831,764 · 10th to 90th $588,844 to $1,819,701Professionalmedian $588,844 · 10th to 90th $588,844 to $602,560
$1M$2Mfacility $831,764professional $588,844

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$588,843.66
Median
$831,763.77
Typical High
$1,819,700.86
Aetna
Setting
Professional
Modifier
Global
Typical Low
$588,843.66
Median
$588,843.66
Typical High
$602,559.59
United
Setting
Facility
Modifier
Global
Typical Low
$588,843.66
Median
$588,843.66
Typical High
$724,435.96
United
Setting
Professional
Modifier
Global
Typical Low
$588,843.66
Median
$588,843.66
Typical High
$588,843.66